{
  "batch": "ms_biologic_deep_dive",
  "finding": "Systematic bias in biologic predictions - model cannot distinguish drug targets",
  "validations": [
    {
      "drug": "Volociximab",
      "disease": "multiple sclerosis",
      "evidence": "FALSE_POSITIVE",
      "drug_type": "biologic",
      "reason": "Anti-\u03b15\u03b21 integrin for CANCER, not MS - model confused with MS drugs"
    },
    {
      "drug": "Fontolizumab",
      "disease": "multiple sclerosis",
      "evidence": "WEAK",
      "drug_type": "biologic",
      "reason": "Anti-IFN-gamma for Crohn's, not studied for MS specifically"
    },
    {
      "drug": "Enokizumab",
      "disease": "multiple sclerosis",
      "evidence": "NO_EVIDENCE",
      "drug_type": "biologic",
      "reason": "Anti-IL9, studied for asthma/atopic dermatitis, not MS"
    },
    {
      "drug": "Adecatumumab",
      "disease": "multiple sclerosis",
      "evidence": "FALSE_POSITIVE",
      "drug_type": "biologic",
      "reason": "Anti-EpCAM for CANCER, not MS"
    },
    {
      "drug": "Romosozumab",
      "disease": "multiple sclerosis",
      "evidence": "FALSE_POSITIVE",
      "drug_type": "biologic",
      "reason": "Anti-sclerostin for OSTEOPOROSIS, not MS"
    },
    {
      "drug": "Eptinezumab",
      "disease": "multiple sclerosis",
      "evidence": "FALSE_POSITIVE",
      "drug_type": "biologic",
      "reason": "Anti-CGRP for MIGRAINE prevention, not MS"
    }
  ],
  "false_positive_count": 4,
  "weak_count": 2
}